One-Time gene therapy aims to cure devastating childhood kidney disease

NCT ID NCT06910813

Summary

This study is testing a one-time gene therapy called DFT383 in young children (ages 2-5) with nephropathic cystinosis, a rare and serious genetic disease that damages the kidneys and other organs. The main goals are to see if the treatment is safe and if it can reverse kidney damage and free children from needing daily medication. About 15 children will receive the gene therapy, while another 15 will be observed for comparison.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEPHROPATHIC CYSTINOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Baylor College of Medicine - Texas Children's Hospital (recuiting Cohort 0)

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Emory University School of Medicine - Children's Healthcare of Atlanta (recuiting Cohort 0)

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Stanford University - Stanford Children's Health

    RECRUITING

    Stanford, California, 94305, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of California at San Diego - Rady Children's Hospital

    RECRUITING

    San Diego, California, 92123, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.